Performance of the BODE index in patients with a1-antitrypsin deficiency-related COPD

European Respiratory Journal

Volumn 44, Issue 1, 2014, Pages 78-86

  Thabut, Gabriel ^a,b   Mornex, Jean Francois ^c,d   Pison, Christophe ^e,f   Cuvelier, Antoine ^g,h   Balduyck, Malika ^i,j   Pujazon, Marie Christine ^k   Fournier, Michel ^a,b   AitIlalne, Brahim ^a,b   Porcher, Raphaël ^b,l,m  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f UNIV GRENOBLE ALPES   (France)

^g ROUEN UNIVERSITY HOSPITAL   (France)

^h CHU de Rouen   (France)

ⁱ LILLE UNIVERSITY HOSPITAL   (France)

^j UNIV LILLE   (France)

^k SERVICE DE PNEUMOLOGIE   (France)

^l Institut Cochin   (France)

^m SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DYSPNEA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FRANCE; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; AGED; ALPHA 1-ANTITRYPSIN DEFICIENCY; AREA UNDER THE CURVE; CALIBRATION; COMPLICATION; COMPUTER PROGRAM; EMPHYSEMA; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VALIDATION STUDY;

ADULT; AGED; ALPHA 1-ANTITRYPSIN DEFICIENCY; AREA UNDER CURVE; CALIBRATION; EMPHYSEMA; FEMALE; FRANCE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROC CURVE; SEVERITY OF ILLNESS INDEX; SOFTWARE; TREATMENT OUTCOME;

EID: 84900806143     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00168113     Document Type: Article

References (34)

1. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
2. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379: 1341-1351.
3. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-773.
4. World Health Organization. World health statistics. www.who.int/whosis/ whostat/EN-WHS08-Full.pdfDatelastaccessed:March2013.Datelastupdated:2008.
5. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-2128.
6. Stoller JK, Aboussouan LS. A review of a1-antitrypsin deficiency. Am J Respir Crit Care Med 2012; 185: 246-259.
7. Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 1986; 89: 370-373.
8. Celli BR. Predictors of mortality in COPD. Respir Med 2010; 104: 773-779.
9. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.
10. Martinez FJ, Han MK, Andrei AC, et al. Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med 2008; 178: 491-499.
11. Lahzami S, Bridevaux PO, Soccal PM, et al. Survival impact of lung transplantation for COPD. Eur Respir J 2010; 36: 74-80.
12. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 745-755.
13. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 2012; 31: 1073-1086.
14. Dawwas MF, Davies SE, Griffiths WJ, et al. Prevalence and risk factors for liver involvement in individuals with PiZZ-related lung disease. Am J Respir Crit Care Med 2013; 187: 502-508.
15. Thabut G. Cohorte nationale de patients emphysémateux déficitaires en alpha-1 antitrypsine [National cohort of patients with emphysema and alpha-1 antitrypsin deficiency]. Rev Mal Respir 2005; 22: 1053-1057.
16. Thabut G, Mornex JF, Cuvelier A, et al. Caractéristiques des patients inclus dans la cohorte francaise de patients emphysémateux déficitaires en alpha-1 antitrypsine [Characteristics of the patients included in the French cohort of patients with emphysema caused by alpha-1 antitrypsin deficiency]. Rev Mal Respir 2008; 25: 1115-1122.
17. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
18. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
19. Xiang F, Murray S. Restricted mean models for transplant benefit and urgency. Stat Med 2012; 31: 561-576.
20. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. Am J Respir Crit Care Med 1998; 158: 49-59.
21. Dirksen A, Dijkman JH, Madsen F, et al. A randomized clinical trial of a1-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999; 160: 1468-1472.
22. Dirksen A, Piitulainen E, Parr DG, et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Eur Respir J 2009; 33: 1345-1353.
23. Stockley RA, Parr DG, Piitulainen E, et al. Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respir Res 2010; 11: 136.
24. Therneau TM, Grambsch PM. Modeling survival data. Extending the Cox model. Springer, New York, 2000.
25. Ibrahim JG, Chu H, Chen LM. Basic concepts and methods for joint models of longitudinal and survival data. J Clin Oncol 2010; 28: 2796-2801.
26. Rizopoulos D. JM: An R package for the joint modelling of longitudinal and time-to-event data. J Stat Software 2010; 35: 1-33.
27. Rizopoulos D. Dynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data. Biometrics 2011; 67: 819-829.
28. Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under ROC curves for censored event times with competing risks. submitted for publication. Stat Med 2013; 32: 5381-5397.
29. Harrell FE, Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-387.
30. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000; 56: 337-344.
31. Lederer DJ, Wilt JS, DOvidio F, et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med 2009; 180: 887-895.
32. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173: 79-83.
33. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374: 704-711.
34. Puhan MA, Hansel NN, Sobradillo P, et al. Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts. BMJ Open 2012; 2: e002152. 35 Mant J, Wilson S, Parry J, et al. Clinicians didnt reliably distinguish between different causes of cardiac death using case histories. J Clin Epidemiol 2006; 59: 862-867.